With the growing appreciation that changes to specific molecules can reflect the broader biochemical anomalies arising from the cancer state, the study of lipids and small-molecule metabolites has become increasingly important for cancer research. The objective of the Virginia Commonwealth University (VCU) Lipidomics/Metabolomics Core (VLMC) is therefore to provide cost effective lipid and small-metabolite analyses for VCU Massey Cancer Center (MCC) members. The VLMC supports the ability of MCC members to qualitatively and highly quantitatively investigate the lipidome and metabolome both in vitro and in vivo studies involving cancer cell lines, preclinical animal models of cancer, and/or patients with cancer. The VLMC does so by providing and maintaining a dedicated advanced lipidomic and metabolomic instrumentation suite that is nationally competitive. Specifically, the VLMC maintains 4 advanced QTRAP-type mass analyzers, each equipped with an ultra-performance liquid chromatography (UPLC) system. An additional quadrupole time-of- flight mass analyzer is equipped with a differential mobility source and a UPLC. In addition to instrumentation, the VLMC has developed, deployed, and proven state-of-the-art methodologies that contemplate overlapping targeted, semi-targeted, and non-targeted approaches to the identification and quantification of changes to the lipidome and metabolome in a high-throughput fashion and over a large dynamic range. The resource is directed by Charles Chalfant, PhD, who is supported by the technical director, D. Shanaka Wijesinghe, PhD, and an additional 2.0 FTEs. The resource director and/or staff support MCC programmatic science by providing consultative services for experimental design and data interpretation, method development, education to certify end-users in the use of the equipment, operator-assisted analysis, and instrument maintenance. The VLMC is a jointly managed (MCC and VCU) resource within close walking distance of MCC. Standard hours for the facility are 9:00 AM until 5:00 PM, Monday through Friday, with certified users enjoying access 24 hours per day, 7 days per week. The usage of services and equipment is tracked and charged back. The VLMC adds significant value to MCC research by providing services that are critical to addressing the research questions of MCC members, services that otherwise would not be practically obtainable or would be cost prohibitive through alternative vendors or even other non-profit institutions. Overall, the instrumentation and expertise available in the VLMC have facilitated the development of a growing user base of MCC members, whose cancer-related research routinely garners peer-reviewed national funding and is published in high-impact scientific journals.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016059-37
Application #
9483640
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2018-05-01
Budget End
2019-04-30
Support Year
37
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Virginia Commonwealth University
Department
Type
DUNS #
105300446
City
Richmond
State
VA
Country
United States
Zip Code
23298
Booth, Laurence; Roberts, Jane L; Rais, Rumeesa et al. (2018) [Neratinib + Valproate] exposure permanently reduces ERBB1 and RAS expression in 4T1 mammary tumors and enhances M1 macrophage infiltration. Oncotarget 9:6062-6074
Floros, Konstantinos V; Lochmann, Timothy L; Hu, Bin et al. (2018) Coamplification of miR-4728 protects HER2-amplified breast cancers from targeted therapy. Proc Natl Acad Sci U S A 115:E2594-E2603
Warthan, Michelle D; Washington, Sonya L; Franzese, Samone E et al. (2018) The role of endoplasmic reticulum aminopeptidase 2 in modulating immune detection of choriocarcinoma. Biol Reprod 98:309-322
Lv, Dong-Wen; Zhang, Kun; Li, Renfeng (2018) Interferon regulatory factor 8 regulates caspase-1 expression to facilitate Epstein-Barr virus reactivation in response to B cell receptor stimulation and chemical induction. PLoS Pathog 14:e1006868
Rizzo, Juliana; Colombo, Ana C; Zamith-Miranda, Daniel et al. (2018) The putative flippase Apt1 is required for intracellular membrane architecture and biosynthesis of polysaccharide and lipids in Cryptococcus neoformans. Biochim Biophys Acta Mol Cell Res 1865:532-541
Brabec, Viktor; Kasparkova, Jana; Menon, Vijay et al. (2018) Polynuclear Platinum Complexes. Structural Diversity and DNA Binding. Met Ions Life Sci 18:
Liu, Runping; Li, Xiaojiaoyang; Huang, Zhiming et al. (2018) C/EBP homologous protein-induced loss of intestinal epithelial stemness contributes to bile duct ligation-induced cholestatic liver injury in mice. Hepatology 67:1441-1457
Moro, Kazuki; Kawaguchi, Tsutomu; Tsuchida, Junko et al. (2018) Ceramide species are elevated in human breast cancer and are associated with less aggressiveness. Oncotarget 9:19874-19890
Talukdar, Sarmistha; Pradhan, Anjan K; Bhoopathi, Praveen et al. (2018) MDA-9/Syntenin regulates protective autophagy in anoikis-resistant glioma stem cells. Proc Natl Acad Sci U S A 115:5768-5773
Luzi, Nicole M; Lyons, Charles E; Peterson, Darrell L et al. (2018) Kinetics and inhibition studies of the L205R mutant of cAMP-dependent protein kinase involved in Cushing's syndrome. FEBS Open Bio 8:606-613

Showing the most recent 10 out of 586 publications